According to Cytosorbents's latest financial reports the company's current EPS (TTM) is -โน51.77. In 2022 the company made an earnings per share (EPS) of -โน64.71 a decrease over its 2021 EPS that were of -โน49.18.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน49.09 | -24.14% |
2022 | -โน64.71 | 31.58% |
2021 | -โน49.18 | 171.43% |
2020 | -โน18.12 | -64.41% |
2019 | -โน50.91 | 5.36% |
2018 | -โน48.32 | 86.67% |
2017 | -โน25.88 | -36.17% |
2016 | -โน40.55 | 27.03% |
2015 | -โน31.92 | -67.55% |
2014 | -โน98.38 | 14.02% |
2013 | -โน86.28 | 33.33% |
2012 | -โน64.71 | -25% |
2011 | -โน86.28 | -20% |
2010 | -โน107.85 | -37.5% |
2009 | -โน172.56 | -50% |
2008 | -โน345.13 | -11.11% |
2007 | -โน388.27 | -80.88% |
2006 | -โน2,031 |